Magnetosomes, the organelles of magnetotactic bacteria, have nanometer-sized magnetic crystals surrounded by a lipid bilayer membrane and organize into chains via a dedicated cytoskeleton within the cell. Magnetosome proteins include approximately 30 proteins in M. gryphiswaldense MSR-1 and 78 proteins in M. magneticum AMB-1. These proteins are involved in the formation of magnetites. Mms 16, MpsA and Mms24 are responsible for mediating the invagination of the cytoplasmic membrane to form magnetosomes. MamJ and MamK are involved in magnetosome chain formation. MagA, MamB and MamM participate in iron transport into magnetosomes. Mms6 initiates magnetite crystal formation and/or morphological regulation. In honeybees, iron deposition begins on the second day after eclosion in the iron deposition vesicles of trophocytes. A cloudy layer just beneath the inner IDV membrane plays an important role in the formation of 7.5-nm spherical iron particles. Subsequently, iron granules are formed by orderly aggregation of the 7.5-nm spherical iron particles in the center of the IDVs. Finally, superparamagnetic magnetite is formed in the center of mature IGs. However, even though magnetite has been demonstrated in honeybees, neither the proteins involved in the formation of Sweroside the 7.5-nm spherical iron particles nor the proteins that convey these tiny particles to the centers of IDVs have been identified, nor has the iron deposition microenvironment of IDVs been characterized. In this study, we purified the proteins from IGs and IDVs and prepared their antibodies. We then use immunofluoresence-labeling, immunogold labeling, and co-immunoprecipitation techniques to examine the mechanism of magnetite biomineralization in the IDVs of honeybees. A previous study on magnetotactic bacteria showed that ferrous ion is present in the cytoplasm and the magnetosome in these bacteria and that this is responsible for carrying out magnetite biomineralization. Additionally, magnetite was formed in an artificial vesicle containing ferrous ion when the pH was increased from 4 to 12. Therefore, we speculate that ferrous ion may also be present in the cytoplasm in honeybees for the purpose of carrying out magnetite biomineralization. Ferrous ion would then be transported into the acidic space between the outer and inner IDV membranes. It has been observed that the Pulchinenoside A spherical iron particles spontaneously move to the center of IDVs in an orderly fashion. This observation suggests that a regular route for ferritin transport may exist in the lumen of IDVs and a putative actin-myosin-ferritin system may play the role of the transporter in this process. An actin chain serves as the route of transport with one end of a myosin molecule being attached to the actin chain and another end to ferritin, which allows myosin to carry ferritin along the actin chain to the center of IDVs. This reaction requires Ca2+ and ATP, and we also identified ATP synthase in purified IGs and IDVs. This putative system could reasonably explain the function of calcium and phosphate in IGs because energy dispersive X-ray spectrum analysis showed that iron, calcium, and phosphate were present in IGs. In magnetotactic bacteria, it has been demonstrated that an ATPase that is essential for iron trafficking is present in the cytoplasm. Thus the mechanisms by which mutations in this gene can induce dopaminergic cell death are a major focus of interest for those seeking to define the molecular pathogenesis of PD. The function of the PINK1 protein is not yet defined, although it is known to be targeted to mitochondria, a significant component of PD pathogenesis and is thought to be involved in protection against free radical generation.
lending an evidence to support that asynuclein expression levels may not affect mitochondrial morphogenesis directly
Owing to lack of the structural basis, a-synuclein may not be able to direct mitochondrial fission or fusion. Although Kamp et al. described that a-synuclein could inhibit protein-free model membrane fusion in vitro, but the concentration of a-synuclein in these reactions was much higher than in normal cells. Therefore, it is difficult to rule out a possibility that it may be the result of a simple physical action. a-Synuclein protein is specific to the vertebrate and expresses at high levels in the brain, especially within developing neurons, suggesting its roles in the development of central nervous system. Supposing that a-synuclein directly regulates mitochondrial dynamics, mitochondrial fission/fusion machinery in vertebrate neurons would be very different from that in other types of cells in vertebrate or in non vertebrate neurons, yet there is no evidence to support this hypothesis. When cells become malignant, some of them, such as Hela cells, start to express a-synuclein while the normal cells would not, nonetheless, no data indicate that excessive mitochondrial fission was found in the malignant cells. Additionally, mitochondria are shorter in immature cells than in mature cells, and mitochondrial fission is essential for embryonic development. Mice lacking the mitochondrial fission GTPase Drp1 have developmental abnormalities and die after embryonic day 12.5 and neural cell-specific Drp1 null mice die shortly after birth. Although a-synuclein expression levels are pretty higher in embryos or infants than in adults, mice lacking a-synuclein show only subtle Arctiin abnormalities in neurotransmission, lending an evidence to support that asynuclein expression levels may not affect mitochondrial morphogenesis directly. Since suppression of a-synuclein has potential values for therapy of PD and related diseases, it is of great biological importance that a-synuclein would not play a key role in essential physiological functions. In conclusion, our results demonstrate that neither a-synuclein expression levels nor its localization to mitochondria affects mitochondrial dynamics. But, this does not mean that a-synuclein is in no way involved in regulation of mitochondrial dynamics. In fact, we found that a-synuclein participates in MPP+ induced mitochondrial fragmentation, suggesting that environmental risk factors may be essential for a-synuclein to gain a function to be involved into mitochondrial dynamics,Naringin dihydrochalcone which required further studies. Recently, genetic contributions in PD pathology have received much attention, but cross-sectional twin studies found that even within families affected by monogenic PD, the age of onset, symptoms and end-stage pathology may be quite variable. More than that, no obvious connections were found in PD patients between a-synuclein expression and neuronal damage. In fact, a-synuclein protein levels are far higher during early human development than late when PD usually occurs, and a-synuclein mRNA label is strong in both affected and unaffected neurons in PD. A possible explanation is that certain environmental exposure is necessary for wild-type asynuclein to gain its toxicity in PD patients, and our results may lend evidences to support the hypothesis. Magnetite biomineralization occurs at ambient temperature, pressure, and pH in a variety of organisms, including magnetotactic bacteria, honeybees, chitons, trouts, and homing pigeons. One of the best understood examples of magnetite biomineralization is in magnetotactic bacteria, which carry out magnetite biomineralization in magnetosomes. Magnetotactic bacteria are a diverse group of microorganisms with the ability to use geomagnetic fields for orientation.
These indicate that more a-synuclein co-localizes with mitochondria in a-synuclein overexpressed cells
As shown in Figure 1, mitochondrial length in SH-SY5Y cells remained almost the same after fixation for 30 min, and no excessive mitochondrial fragmentation was observed, suggesting that mitochondrial morphology in live cells is well reserved by fixation. Similar results were seen in other two cell lines. It is suggested that the mitochondrial fragmentation induced by a-synuclein overexpression may be due to its localization on mitochondria. To examine whether a-synuclein localization on mitochondria was promoted after SNCA transfection in our experiment, we isolated mitochondria and analyzed mitochondrial a-synuclein expression by immunoblotting. Mitochondrial or cytosolic extracts were first examined by immunoblotting for the presence of cytochrome oxidase subunit IV and b-actin. A robust band of COX IV was detected from the mitochondrial extracts, while the b-actin band was pretty weak; they were opposite in the cytosolic fraction, suggesting that the mitochondrial fraction was enriched with mitochondria, while few mitochondria were detected in the cytosolic fraction. a-Synuclein expression in mitochondrial pellets was very low in SH-SY5Y, PC12 and Hela cells, yet it was remarkably increased in all three cell lines after SNCA transfection for 48 h. Representative double-staining images of mitochondria and asynuclein demonstrated that after SNCA transfection for Nimorazole, asynuclein expression in all three cell lines was significantly increased and its distribution was greatly changed compared with those in the cells transfected with an empty vector. a-Synuclein was highly enriched in the nucleus in Hela and PC12 cells after SNCA transfection, and its expression was also strong in the nucleus in SH-SY5Y cells, but even stronger in the cytoplasm. a-Synuclein was expressed all over the cytoplasm in PC12 cells, where some peculiar punctate staining of a-synuclein was more standout and mostly co-localized with mitochondria, as shown in the amplified images in Figure S3. Cytofluorogram analysis of those double-staining images demonstrated that in all three cell lines, PC coefficients in a-synuclein overexpressed cells were magnificently elevated compared with the cells transfected with an empty vector. These indicate that more a-synuclein co-localizes with mitochondria in a-synuclein overexpressed cells. Although mitochondrial localization of a-synuclein was increased following SNCA transfection,Euphorbia factor L3 mitochondria in three cell lines still remain an elongated tubular and thread-like shape and no significant change in mitochondrial length was detected between a-synuclein overexpressed cells and those transfected with an empty vector. This indicates that a-synuclein overexpression increases its localization on mitochondria without affecting mitochondrial morphology in cell lines. Mitochondria undergo continuous fission and fusion in living cells, which is necessary for maintaining mitochondrial network morphology and physiological functions. Mitochondrial fission and fusion were first described in yeast, and found that it is mediated by a group of large GTPases. Although their precise mechanism of action is unclear, the conservation of these GTPases across species suggests that there are some similar mechanisms of mitochondrial dynamics between mammalian cells and yeast. In addition to these GTPases, other proteins have been implicated in the regulation of mitochondrial fusion and fission in mammalian cells, however, almost all of them participate in the regulation of mitochondrial dynamics by interacting with these GTPases. For example, mitochondria-associated PTENinduced kinase 1, a protein linked to familial PD, regulates mitochondrial dynamics through interaction with the fission/fusion machinery.
a-synuclein lacks of rigid and ordered structure under physiological conditions in vitro
Buttner et al. showed that depletion of mitochondria DNA in yeast inhibits ROS formation and cell apoptosis induced by a-synuclein, further suggesting a direct functional connection between a-synuclein and mitochondria. More than those, a series of articles indicates that asynuclein may directly interact with mitochondria. We reported that, in addition to its predominantly cytosolic and vesicular localization, a fraction of a-synuclein localizes in the mitochondria under physiological condition, which is confirmed by many other studies. Nevertheless, the normal function and pathogenic role of mitochondrial a-synuclein need further investigation. Recently, Kamp et al. reported that a-synuclein has an inhibitory function on membrane fusion, and it binds to mitochondria and directly leads to mitochondrial fragmentation when overexpressed in cell cultures and Caenorhabditis elegans. In addition, Nakamura et al. described that the effect is not accompanied by changes in the morphology of other organelles, including endoplasmic reticulum and lysosomes. This may reveal a novel model of mitochondrial dynamic regulation,Nedaplatin yet some questions remains unanswered: Since recombinant asynuclein induces fission of artificial membranes, why does it have no influence on other lipid membranes in cells, such as ER and lysosomes, except mitochondria? Therefore, more direct evidence is needed to show the role of a-synuclein levels in mitochondrial morphology. Mitochondria and a-synuclein were double-stained in this study, which not only allows us to compare mitochondrial morphology and a-synuclein expression and distribution among three distinct cell lines, including Hela, SH-SY5Y and PC12 cells, but also to directly assess mitochondrial morphological changes in cells following a-synuclein overexpression. Our results indicate that a-synuclein expression levels has little influence on mitochondrial morphology in normal cells, but knockdown of asynuclein prevents MPP + -induced mitochondrial fragmentation in SH-SY5Y and PC12 cells. These data imply that a-synuclein plays no role in mitochondrial morphology under normal condition,Terutroban but may have some effect on that at the presence of certain environment factors. To observe the effects of a-synuclein overexpression on mitochondrial morphology, we need to track down a-synuclein overexpressed cells. However, some traditional approaches may be unsuitable for a-synuclein, such as fluorescent protein tags used in many papers. As a typical natively unfolded protein, a-synuclein lacks of rigid and ordered structure under physiological conditions in vitro, and its structure depends extremely on its environment and accommodates a number of unrelated conformations, which might affect its functions accordingly. If asynuclein was tagged with a fluorescent protein, whose molecular weight is even bigger than a-synuclein, we could not guarantee that this would not affect its structure or functions. Similar problems may remain when a fluorescent protein is co-transfected as an independent reporter. Another option is to transfect cells with untagged full length human SNCA cDNA, stain live cells with MitoTracker, fix them and then process for immunofluorescence staining of a-synuclein, since MitoTracker Red CMXRos stains mitochondria in live cells and is well-retained in fixed, permeabilized cells. Mitochondrial length is usually used to assess mitochondrial morphology in live cells, thus firstly, we need to test whether mitochondrial length would be affected by cell fixation. SH-SY5Y, PC12 or Hela cells were stained with MitoTracker-Red CMXRos and then observed on live cell imaging system using a 1006objective. Images of the same cells were taken immediately before and 30 min after fixation with 4% paraformaldehyde to detect mitochondrial morphogenetic alterations, one image often covers 1–2 SH-SY5Y or Hela cells or 4–8 PC12 cells, and the experiment was carried out five times for each cell line.
we speculated that Snail might interact with various classes of histone deacetylases in complexes
Interestingly, there are 2 E-box sequences in RELN promoter region, and we identified the recruitment of transcriptional repressor Snail to the RELN promoter after TGF-b1 treatment. In addition, we observed elevated expression of RELN mRNA after treatment with the histone deacetylase inhibitor, TSA, in ESCC cells, and Snail was also reported to be interacted with HDAC1 to repress E-cadherin expression. And RELN promoter was epigenetically regulated through DNA methylation. Equally important in this context is the interplay between methylation, chromatin structure and histone deacetylation. Thus, we speculated that Snail might interact with various classes of histone deacetylases in complexes that repress RELN transcription and perhaps induce histone deacetylation in ESCC cells. Recently, several groups reported that loss of functional Reelin was implicated in motility and invasion of pancreatic, gastric, and breast cancer. Our previous study showed that Reelin was dysregulated in ESCC samples. In this study, knockdown of Reelin expression considerably enhanced mobility of ESCC cells, which is consistent with previous reports. Unfortunately, further examination on ESCC specimens failed to find a significant correlation between RELN expression and clinical metastasis status. One possible explanation is Oxysophocarpine that there are limited amount of metastatic cancer cells in the tested specimens. Another reason rests on multiple steps of metastasis. Because metastasis consists of a serial of procedures and we have not determined in which steps RELN may be involved. Therefore, the result in ESCC tissues is not necessarily in conflict with the finding that RELN suppressed cell migration of human ESCC cells. In summary, Reelin is involved in TGF-b1-mediated cell migration in ESCC cells, and the TGF-b1-induced migration could be suppressed by Reelin expression. We further demonstrated that Snail can regulate Reelin expression through binding to Reelin promoter region in vivo after TGF-b1 treatment and decreased RELN promoter activity in a dose-dependent manner. And we showed that knockdown of Reelin induced the expression of mesenchymal markers and increased cell migration in KYSE510 cells. Our results provide the first evidence linking Reelin to TGF-b signal pathway, which contribute to cancer metastasis, and it is helpful for anti-cancer strategies. a-Synuclein is a small and natively unfolded protein, and it is the first member of synuclein family which is named as earlier studies showed that a-synuclein only localizes in presynaptic terminals and nucleus. Yet later, a-synuclein was shown in the somata of specific neuronal populations in the rat brain, e.g. in the SNpc, using a monoclonal antibody. a-Synuclein has attracted considerable attention due to its involvement in neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease. Beyond those,Diisopropylammonium dichloroacetate aberrant expression of a-synuclein may be highly associated with human malignancies. However, less is known about its normal function. Several studies already noticed some connection between asynuclein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a well characterized neurotoxin for inducing PD models at present, which oxidized in vivo into the toxic substrate 1methyl-4-phenylpyridinium. Vila et al. found that MPTP enhances a-synuclein expression in vivo ; Dauer et al. reported that a-synuclein is required for MPTP-induced apoptosis as a-synuclein null mice presents striking resistance to MPTP. These studies established a model to link environmental and genetic factors in PD-like cell death; still, the mechanism underlying is poorly elucidated. Lately, a pathogenic link between a-synuclein and mitochondria was established by the observations that some transgenic mice overexpressing wild-type or mutant a-synuclein develop abnormal mitochondrial morphology.